Q32 Bio Inc. (QTTB)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 17.95 |
| Open | 17.90 |
| Bid | 18.54 x 100 |
| Ask | 19.17 x 100 |
| Day's range | 17.46 - 19.04 |
| 52-week range | 8.24 - 32.88 |
| Volume | |
| Avg. volume | 62,051 |
| Market cap | 226.661M |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -4.51 |
| Earnings date | 12 Aug 2024 - 16 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 62.25 |
PR NewswireQ32 Bio Joins Russell 3000® Index
Q32 Bio Inc. (Nasdaq: QTTB) ("Q32 Bio"), a clinical stage biotechnology company focused on developing biologic therapeutics to restore immune homeostasis, today announced that the company is joining the broad-market Russell 3000® Index at the conclusion of the 2024 Russell Indexes annual reconstitution, effective upon the U.S. market opening today, July 1, 2024.
Simply Wall St.Q32 Bio Inc.'s (NASDAQ:QTTB) last week's 15% decline must have disappointed private equity firms who have a significant stake
Key Insights Q32 Bio's significant private equity firms ownership suggests that the key decisions are influenced by...
- PR Newswire
Q32 Bio Reports First Quarter 2024 Financial Results and Provides Corporate Update
Q32 Bio Inc. (NASDAQ: QTTB) ("Q32 Bio"), a clinical stage biotechnology company focused on developing biologic therapeutics to restore immune homeostasis, today reported financial results for the quarter ended March 31, 2024 and provided recent corporate updates.
© 2024 Yahoo. All rights reserved.